MDCL Stock Overview
Mediclinic International plc, together with its subsidiaries, operates private hospitals.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Mediclinic International plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£5.00 |
| 52 Week High | UK£5.02 |
| 52 Week Low | UK£3.89 |
| Beta | 0.42 |
| 1 Month Change | 0.41% |
| 3 Month Change | 0.41% |
| 1 Year Change | 25.38% |
| 3 Year Change | 66.97% |
| 5 Year Change | -14.87% |
| Change since IPO | -44.06% |
Recent News & Updates
Recent updates
Shareholder Returns
| MDCL | GB Healthcare | GB Market | |
|---|---|---|---|
| 7D | 0% | 1.3% | -1.2% |
| 1Y | 25.4% | -25.0% | 6.9% |
Return vs Industry: MDCL exceeded the UK Healthcare industry which returned 5.1% over the past year.
Return vs Market: MDCL exceeded the UK Market which returned -2.4% over the past year.
Price Volatility
| MDCL volatility | |
|---|---|
| MDCL Average Weekly Movement | 0.5% |
| Healthcare Industry Average Movement | 7.3% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 11.1% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: MDCL has not had significant price volatility in the past 3 months.
Volatility Over Time: MDCL's weekly volatility (0%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | 33,683 | Ronnie van der Merwe | www.mediclinic.com |
Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers specialist-orientated and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 74 hospitals, 20 day case clinics, 22 outpatient clinics, 5 subacute hospitals, 2 mental health facilities, and 453 theatres with approximately 11,538 inpatient beds in Switzerland, South Africa, Namibia, the Middle East, and the United Kingdom.
Mediclinic International plc Fundamentals Summary
| MDCL fundamental statistics | |
|---|---|
| Market cap | UK£3.69b |
| Earnings (TTM) | UK£169.00m |
| Revenue (TTM) | UK£3.38b |
21.9x
P/E Ratio1.1x
P/S RatioIs MDCL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MDCL income statement (TTM) | |
|---|---|
| Revenue | UK£3.38b |
| Cost of Revenue | UK£2.66b |
| Gross Profit | UK£728.00m |
| Other Expenses | UK£559.00m |
| Earnings | UK£169.00m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.23 |
| Gross Margin | 21.52% |
| Net Profit Margin | 5.00% |
| Debt/Equity Ratio | 54.1% |
How did MDCL perform over the long term?
See historical performance and comparison